Understanding the full scope of AD—the unseen burden on patients.

The progression of autoimmune type 1 diabetes (T1D) is gradual, often detectable months or even years before symptoms arise.^1–3 Through proactive screening, we can identify the condition well in advance.³ Meet our ambassadors living with autoimmune T1D and discover the risk factors to look out for when considering who to screen.

Individuals living with other associated autoimmune diseases like celiac disease or autoimmune thyroid disease, are at an increased risk of developing autoimmune type 1 diabetes (T1D) and should be appropriately screened.^1-6

Autoimmune type 1 diabetes (T1D) is a progressive disease in which the decline in beta cell function usually begins months or sometimes years before clinical symptoms are observed.^1–3 You can identify such patients at risk of developing autoimmune T1D before clinical symptoms are noticed by you or your patient.³

Delay in screening for autoimmune type 1 diabetes (T1D) can increase the risk of diabetic ketoacidosis (DKA) at diagnosis—a critical complication that is potentially life-threatening and may result in long-term poor glycemic control and neurological complications.^1,2 By identifying autoimmune T1D early, you can significantly lower the risk of DKA at diagnosis.^3,4

Individuals who screen positive for ≥1 autoimmune islet cell antibodies need periodic medical monitoring, which includes regular assessments of blood glucose and HbA1c levels. You can also educate them about symptoms of diabetes, diabetic ketoacidosis (DKA), and provide psychosocial support to prepare them for a possible clinical diagnosis for type 1 diabetes (T1D).¹

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.^1-4 

The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2

A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.

Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences. Each episode features esteemed guests, including experts and patients, offering valuable insights into the evolving world of CRSwNP.

What links CRSwNP, asthma, and other comorbidities? In this episode, our experts unpack the unified airways concept and why it’s key to understanding Type 2 inflammation and optimizing patient care. Our experts discuss integrated care approaches and what they mean for clinical practice.

In this episode of Polyp Gossip, we explore the importance of a multidisciplinary approach in managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Join leading experts from rhinology and pulmonology as they discuss how collaboration across specialties can improve patient outcomes and optimize care pathways.

In this episode we explore the critical decision of whether surgery is the right choice for CRSwNP patients. Leading experts discuss the factors influencing surgical vs. medical management, patient considerations, and the latest advancements in treatment. Tune in for an in-depth look at this big decision in CRSwNP care!